IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch

J Nephrol. 2023 Nov;36(8):2375-2380. doi: 10.1007/s40620-023-01583-2. Epub 2023 Mar 13.

Abstract

We report the case of a 31-year-old male who presented with repeated episodes of nephritic-nephrotic syndrome in concomitance with infection. IgA was diagnosed and was initially responsive to treatment with immunosuppressors but further disease flare did not respond to treatment. Based on three consecutive renal biopsies over 8 years, a pattern switch from endocapillary proliferative IgA nephropathy to membranous proliferative glomerulonephritis with monoclonal IgAκ deposits was observed. Bortezomib-dexamethasone combination therapy finally led to a favorable renal response. This case provides new insights into the pathophysiological mechanisms of proliferative glomerulonephritis with monoclonal immunoglobin deposits (PGNMID), highlighting the importance of repeat renal biopsies and routine evaluation of monoclonal immunoglobin deposits in proliferative glomerulonephritis with refractory nephrotic syndrome.

Keywords: IgA nephropathy; Membranoproliferative glomerulonephritis; Monoclonal gammopathy of renal significance; Proliferative glomerulonephritis with monoclonal immunoglobulin deposits; Refractory nephrotic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Glomerulonephritis* / pathology
  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / diagnosis
  • Glomerulonephritis, IGA* / drug therapy
  • Glomerulonephritis, Membranoproliferative* / diagnosis
  • Glomerulonephritis, Membranoproliferative* / drug therapy
  • Humans
  • Immunoglobulin G
  • Male
  • Nephrotic Syndrome*

Substances

  • Immunoglobulin G